メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer

  • Kohei Yamashita
  • , Masaaki Iwatsuki
  • , Noriko Yasuda-Yoshihara
  • , Takeshi Morinaga
  • , Yosuke Nakao
  • , Kazuto Harada
  • , Kojiro Eto
  • , Junji Kurashige
  • , Yukiharu Hiyoshi
  • , Takatsugu Ishimoto
  • , Yohei Nagai
  • , Shiro Iwagami
  • , Yoshifumi Baba
  • , Yuji Miyamoto
  • , Naoya Yoshida
  • , Jaffer A. Ajani
  • , Hideo Baba

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

44   !!Link opens in a new tab 被引用数 (Scopus)

抄録

Background: The predictive significance of programmed death ligand 1 (PD-L1) for programmed death 1 (PD-1) inhibitors remains unclear in gastric cancer (GC) due to the dynamic alteration by treatments. We aimed to elucidate the effects of trastuzumab (Tmab) on PD-L1 expression in GC. Methods: PD-L1 expression was evaluated by multicolour flow cytometry analysis after co-culturing GG cell lines and immune cells with Tmab. IFN-γ in the co-culture experiments was quantified. Immunohistochemistry (IHC) for PD-L1 expression using clinical samples was also performed to confirm PD-L1 alteration by Tmab. Results: PD-L1 expression was significantly upregulated by Tmab in HER2-amplified GC cell lines co-cultured with peripheral blood mononuclear cells (PBMCs). PD-L1 upregulation by Tmab was also observed in the GC cells co-cultured with NK cells in time-dependent manner, but not with monocytes. IFN-γ concentration in conditioned media from co-cultured PBMCs and NK cells with Tmab was significantly higher and anti-IFN-γ significantly suppress the Tmab-induced PD-L1 upregulation. IHC also suggested PD-L1 upregulation after Tmab treatment. Conclusions: Tmab can upregulate PD-L1 expression on GC cells through interaction with NK cells. These results suggest clinical implications in the assessment of the predictive significance of PD-L1 expression for PD-1 inhibitors.

本文言語英語
ページ(範囲)595-603
ページ数9
ジャーナルBritish journal of cancer
巻124
号3
DOI
出版ステータス出版済み - 2月 2 2021
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

!!!All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究

フィンガープリント

「Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル